Global Rosuvastatin Calcium Market Growth 2019-2024
Table of Contents
2019-2024 Global Rosuvastatin Calcium Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Rosuvastatin Calcium Consumption 2014-2024
- 2.1.2 Rosuvastatin Calcium Consumption CAGR by Region
- 2.2 Rosuvastatin Calcium Segment by Type
- 2.2.1 Purity 98.0%
- 2.2.2 Purity 99.0%
- 2.2.3 Other
- 2.3 Rosuvastatin Calcium Consumption by Type
- 2.3.1 Global Rosuvastatin Calcium Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Rosuvastatin Calcium Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Rosuvastatin Calcium Sale Price by Type (2014-2019)
- 2.4 Rosuvastatin Calcium Segment by Application
- 2.4.1 Tablet (including dispersible tablet and general tablet)
- 2.4.2 Capsule
- 2.4.3 Others
- 2.5 Rosuvastatin Calcium Consumption by Application
- 2.5.1 Global Rosuvastatin Calcium Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Rosuvastatin Calcium Value and Market Share by Application (2014-2019)
- 2.5.3 Global Rosuvastatin Calcium Sale Price by Application (2014-2019)
3 Global Rosuvastatin Calcium by Players
- 3.1 Global Rosuvastatin Calcium Sales Market Share by Players
- 3.1.1 Global Rosuvastatin Calcium Sales by Players (2017-2019)
- 3.1.2 Global Rosuvastatin Calcium Sales Market Share by Players (2017-2019)
- 3.2 Global Rosuvastatin Calcium Revenue Market Share by Players
- 3.2.1 Global Rosuvastatin Calcium Revenue by Players (2017-2019)
- 3.2.2 Global Rosuvastatin Calcium Revenue Market Share by Players (2017-2019)
- 3.3 Global Rosuvastatin Calcium Sale Price by Players
- 3.4 Global Rosuvastatin Calcium Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Rosuvastatin Calcium Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Rosuvastatin Calcium Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Rosuvastatin Calcium by Regions
- 4.1 Rosuvastatin Calcium by Regions
- 4.1.1 Global Rosuvastatin Calcium Consumption by Regions
- 4.1.2 Global Rosuvastatin Calcium Value by Regions
- 4.2 Americas Rosuvastatin Calcium Consumption Growth
- 4.3 APAC Rosuvastatin Calcium Consumption Growth
- 4.4 Europe Rosuvastatin Calcium Consumption Growth
- 4.5 Middle East & Africa Rosuvastatin Calcium Consumption Growth
5 Americas
- 5.1 Americas Rosuvastatin Calcium Consumption by Countries
- 5.1.1 Americas Rosuvastatin Calcium Consumption by Countries (2014-2019)
- 5.1.2 Americas Rosuvastatin Calcium Value by Countries (2014-2019)
- 5.2 Americas Rosuvastatin Calcium Consumption by Type
- 5.3 Americas Rosuvastatin Calcium Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Rosuvastatin Calcium Consumption by Countries
- 6.1.1 APAC Rosuvastatin Calcium Consumption by Countries (2014-2019)
- 6.1.2 APAC Rosuvastatin Calcium Value by Countries (2014-2019)
- 6.2 APAC Rosuvastatin Calcium Consumption by Type
- 6.3 APAC Rosuvastatin Calcium Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Rosuvastatin Calcium by Countries
- 7.1.1 Europe Rosuvastatin Calcium Consumption by Countries (2014-2019)
- 7.1.2 Europe Rosuvastatin Calcium Value by Countries (2014-2019)
- 7.2 Europe Rosuvastatin Calcium Consumption by Type
- 7.3 Europe Rosuvastatin Calcium Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Rosuvastatin Calcium by Countries
- 8.1.1 Middle East & Africa Rosuvastatin Calcium Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Rosuvastatin Calcium Value by Countries (2014-2019)
- 8.2 Middle East & Africa Rosuvastatin Calcium Consumption by Type
- 8.3 Middle East & Africa Rosuvastatin Calcium Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Rosuvastatin Calcium Distributors
- 10.3 Rosuvastatin Calcium Customer
11 Global Rosuvastatin Calcium Market Forecast
- 11.1 Global Rosuvastatin Calcium Consumption Forecast (2019-2024)
- 11.2 Global Rosuvastatin Calcium Forecast by Regions
- 11.2.1 Global Rosuvastatin Calcium Forecast by Regions (2019-2024)
- 11.2.2 Global Rosuvastatin Calcium Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Rosuvastatin Calcium Forecast by Type
- 11.8 Global Rosuvastatin Calcium Forecast by Application
12 Key Players Analysis
- 12.1 AstraZeneca
- 12.1.1 Company Details
- 12.1.2 Rosuvastatin Calcium Product Offered
- 12.1.3 AstraZeneca Rosuvastatin Calcium Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 AstraZeneca News
- 12.2 Teva Pharmaceutical Industries
- 12.2.1 Company Details
- 12.2.2 Rosuvastatin Calcium Product Offered
- 12.2.3 Teva Pharmaceutical Industries Rosuvastatin Calcium Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Teva Pharmaceutical Industries News
- 12.3 MSN Laboratories
- 12.3.1 Company Details
- 12.3.2 Rosuvastatin Calcium Product Offered
- 12.3.3 MSN Laboratories Rosuvastatin Calcium Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 MSN Laboratories News
- 12.4 Cadila Pharmaceuticals
- 12.4.1 Company Details
- 12.4.2 Rosuvastatin Calcium Product Offered
- 12.4.3 Cadila Pharmaceuticals Rosuvastatin Calcium Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Cadila Pharmaceuticals News
- 12.5 LGM Pharma
- 12.5.1 Company Details
- 12.5.2 Rosuvastatin Calcium Product Offered
- 12.5.3 LGM Pharma Rosuvastatin Calcium Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 LGM Pharma News
- 12.6 Bal Pharma
- 12.6.1 Company Details
- 12.6.2 Rosuvastatin Calcium Product Offered
- 12.6.3 Bal Pharma Rosuvastatin Calcium Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Bal Pharma News
- 12.7 Changzhou Pharmaceutical Factory
- 12.7.1 Company Details
- 12.7.2 Rosuvastatin Calcium Product Offered
- 12.7.3 Changzhou Pharmaceutical Factory Rosuvastatin Calcium Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Changzhou Pharmaceutical Factory News
- 12.8 Jingxin Pharm
- 12.8.1 Company Details
- 12.8.2 Rosuvastatin Calcium Product Offered
- 12.8.3 Jingxin Pharm Rosuvastatin Calcium Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Jingxin Pharm News
- 12.9 Zhejiang Hisun Pharmaceutical
- 12.9.1 Company Details
- 12.9.2 Rosuvastatin Calcium Product Offered
- 12.9.3 Zhejiang Hisun Pharmaceutical Rosuvastatin Calcium Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Zhejiang Hisun Pharmaceutical News
- 12.10 HEC Pharm
- 12.10.1 Company Details
- 12.10.2 Rosuvastatin Calcium Product Offered
- 12.10.3 HEC Pharm Rosuvastatin Calcium Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 HEC Pharm News
- 12.11 Lunan Pharmaceutical
- 12.12 Nanjing Frochem Tech
- 12.13 Lianyungang Runzhong Pharmaceutical
- 12.14 Shandong Bechem Chemicals
- 12.15 CTX Life Sciences
- 12.16 Others
13 Research Findings and Conclusion
Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).
With the raw material advantage, EU is the dominate producer and exporter in rosuvastatin calcium industry. The production market share of EU has reached about 35.25% in 2015. In additional, EU is also the largest consumer of rosuvastatin calcium, about 34.47% of the global production was consumed in EU in 2015. China is the second producer with the market share of 28.82% in 2015. Top Three manufacturers in rosuvastatin calcium are AstraZeneca, MSN Laboratories, Changzhou Pharmaceutical Factory, according for 55.09% of the total amount in 2015.
According to this study, over the next five years the Rosuvastatin Calcium market will register a 4.1% CAGR in terms of revenue, the global market size will reach US$ 550 million by 2024, from US$ 430 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Rosuvastatin Calcium business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Rosuvastatin Calcium market by product type, application, key manufacturers and key regions and countries.
This study considers the Rosuvastatin Calcium value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Purity 98.0%
Purity 99.0%
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Tablet (including dispersible tablet and general tablet)
Capsule
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AstraZeneca
Teva Pharmaceutical Industries
MSN Laboratories
Cadila Pharmaceuticals
LGM Pharma
Bal Pharma
Changzhou Pharmaceutical Factory
Jingxin Pharm
Zhejiang Hisun Pharmaceutical
HEC Pharm
Lunan Pharmaceutical
Nanjing Frochem Tech
Lianyungang Runzhong Pharmaceutical
Shandong Bechem Chemicals
CTX Life Sciences
Others
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Rosuvastatin Calcium consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Rosuvastatin Calcium market by identifying its various subsegments.
Focuses on the key global Rosuvastatin Calcium manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Rosuvastatin Calcium with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Rosuvastatin Calcium submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.